Claritev Corporation

$21.24+31.11%(+$5.04)
TickerSpark Score
62/100
Mixed
87
Valuation
60
Profitability
70
Growth
44
Health
50
Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CTEV research report →

52-Week Range16% of range
Low $11.50
Current $21.24
High $74.07

Companywww.claritev.com

Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services that reduce medical costs, through data-driven algorithms and insights that detect claims over-charges and negotiate or recommend reimbursement; and network-based services that provide contracted discounts with healthcare providers, as well as outsourced network development and management services. It provides payment and revenue integrity services, such as identifying and removing improper and unnecessary charges paid during the claim, as well as services to identify and help restore and preserve underpaid premium dollars.

CEO
Travis S. Dalton
IPO
2020
Employees
2,700
HQ
New York City, NY, US

Price Chart

-26.04% · this period
$72.58$43.02$13.47May 20Nov 18May 20

Valuation

Market Cap
$362.09M
P/E
-1.24
P/S
0.37
P/B
-1.47
EV/EBITDA
9.54
Div Yield
0.00%

Profitability

Gross Margin
61.06%
Op Margin
4.29%
Net Margin
-29.27%
ROE
205.84%
ROIC
0.78%

Growth & Income

Revenue
$965.41M · 3.74%
Net Income
$-284,282,000 · 82.73%
EPS
$-17.30 · 83.03%
Op Income
$45.06M
FCF YoY
-16.85%

Performance & Tape

52W High
$74.07
52W Low
$11.50
50D MA
$19.73
200D MA
$39.41
Beta
0.77
Avg Volume
206.20K

Get TickerSpark's AI analysis on CTEV

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Recent Insider Transactions

DateInsiderTypeShares
May 18, 26Kim Michaelbuy3,000
May 19, 26Prince John Michaelbuy10,000
May 18, 26Dalton Travisbuy11,200
May 18, 26Dalton Travisbuy9,720
Apr 29, 26Klapstein Julie Dother8,977
Apr 29, 26Klein Michael Stuartother8,977
Apr 29, 26Clarke Richard Aother8,977
Apr 29, 26Kap Jason Lamarother8,977
Apr 29, 26HARRIS C MARTINother8,977
Apr 29, 26Prince John Michaelother8,977

Our CTEV Coverage

We haven't published any research on CTEV yet

For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.

Generate CTEV Report →

Similar Companies